News
The risk calculator shows improved precision in a population larger than the original dataset used to validate the tool.
Despite a risk for severe side effects, pembrolizumab has a record of improving recurrence-free survival that makes it an ...
It's been the hottest start to May since records began, and with more sun on the way Dr Punam has already seen an increase in ...
The study, which used flow cytometry rather than molecular biology to identify circulating tumor cells (CTCs), found a ...
Research from The University of Western Australia has advanced the development of cancer treatments that enable immune cells ...
This is a sponsored post Ballard residents have a new reason to prioritize their skin health this May. Frontier Dermatology, ...
Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...
Researchers at Novartis BioMedical Research in the US and Switzerland have identified a molecular target that may provide a ...
As Teddi Mellencamp continues to undergo treatment for Stage 4 skin cancer, the former reality star is opening up about her ...
A woman who ignored a "normal" mole on her arm ended up with 77 stitches to remove what was actually stage 2 melanoma — the ...
19h
The Star Press on MSNFreckle or melanoma? How to tell the difference.Summer can mean a rise in visible freckles. But how do you know when a freckle is harmless versus whether it might actually be concerning?
Patients who were positive for cytomegalovirus had more immune cells circulating in their blood before they started ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results